US 8,791,270 · Application 13/969,724 · Granted Jul 29, 2014
US 8,791,270
Bendamustine pharmaceutical compositions
Estimated expiration
January 12, 2026
Expired 245 days ago
Earliest effective filing
Jan 12, 2006
+ 20 years
Jan 12, 2026
PTA +0d
Jan 12, 2026
TD cap (US 8,609,863)
Jan 12, 2026
Final
Jan 12, 2026
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- August 19, 2013
- Earliest effective filing
- January 12, 2006
- Issue date
- July 29, 2014
- PTA
- 0 days
- Base expiry (before PTA)
- January 12, 2026
January 12, 2006 + 20 years = January 12, 2026
- Continuation of application 13/719,409, filed Dec 19, 2012, issued as US 8,895,756
- Continuation of application 13/654,898, filed Oct 18, 2012, issued as US 8,461,350
- Continuation of application 11/330,868, filed Jan 12, 2006, issued as US 8,436,190
- Continuation of application 11/330,868, filed Jan 12, 2006, issued as US 8,436,190
- Continuation of application 13/654,898, filed Oct 18, 2012, issued as US 8,461,350
- Continuation of application 11/330,868, filed Jan 12, 2006, issued as US 8,436,190
- PRO60/644,354 — Provisional — not used for base term
- PRO60/644,354 — Provisional — not used for base term
- PRO60/644,354 — Provisional — not used for base term
- PRO60/644,354 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to January 12, 2026 (earliest expiring referenced patent: US 8,609,863)
US 13,969,724
Could not resolve calculation details
US 8,436,190· Application 11/330,868Capping patent
Bendamustine pharmaceutical compositions
- Filing date
- Jan 12, 2006
- Earliest effective filing
- Jan 12, 2006
- Issue date
- May 7, 2013
- PTA
- +1748 days
- Calculated expiration
- Oct 26, 2030
Jan 12, 2006 + 20y + 1748d PTA = Oct 26, 2030
US 8,609,863· Application 13/719,379Capping patent
Bendamustine pharmaceutical compositions
- Filing date
- Dec 19, 2012
- Earliest effective filing
- Jan 12, 2006
- Issue date
- Dec 17, 2013
- PTA
- 0 days
- Calculated expiration
- Jan 12, 2026
Continuation of 13/654,898, filed Oct 18, 2012, issued as US 8,461,350
Continuation of 11/330,868, filed Jan 12, 2006, issued as US 8,436,190
Continuation of 11/330,868, filed Jan 12, 2006, issued as US 8,436,190
Jan 12, 2006 + 20y = Jan 12, 2026
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 13/969,724 · US 8,791,270
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 8,791,270: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US8791270Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.